Related Experiment Videos
[Do piroxicam and diclofenac impair reaction performance?]
Summary
Piroxicam, a non-steroidal anti-inflammatory drug, enhanced motivation and activation in subjects, unlike diclofenac. Cognitive tests showed no significant performance changes for either drug compared to placebo.
Area of Science:
- Pharmacology
- Neuroscience
- Human Performance Studies
Background:
- Non-steroidal anti-inflammatory drugs (NSAIDs) are widely used for pain and inflammation.
- Understanding the central nervous system effects of NSAIDs beyond analgesia is crucial.
Purpose of the Study:
- To investigate the performance-influencing effects of diclofenac and piroxicam.
- To compare the cognitive and psychometric impacts of these NSAIDs against a placebo.
Main Methods:
- Acute, placebo-controlled, cross-over trial with 11 healthy subjects.
- Administration of diclofenac (1 mg/kg) and piroxicam (0.3 mg/kg).
- Assessment using cognitive tests (vigilance, d2-test, concentration performance, determination, flicker frequency) and a self-state questionnaire.
Main Results:
- No significant verum effects on cognitive performance were observed for diclofenac or piroxicam compared to placebo.
- Piroxicam administration led to significant positive effects on subject motivation and activation.
- Piroxicam also showed trends towards increased outgoingness, exertion, concentration, and relaxation, while diclofenac had no discernible impact.
Conclusions:
- Piroxicam may positively influence subjective states like motivation and activation, independent of cognitive performance changes.
- Diclofenac demonstrated no significant effect on performance or psychological state in this study.
- Further research is warranted to explore the nuanced central nervous system effects of NSAIDs.